Followers | 897 |
Posts | 149197 |
Boards Moderated | 0 |
Alias Born | 08/13/2010 |
Tuesday, January 25, 2022 4:22:27 PM
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Recent VVOS News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/24/2024 06:59:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:05:23 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/20/2024 12:00:29 PM
- Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 09/19/2024 11:00:00 AM
- Healthcare Shares Pop On FDA Clearance • AllPennyStocks.com • 09/18/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2024 12:00:16 PM
- Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring • GlobeNewswire Inc. • 09/18/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 09:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:24:05 PM
- Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 08/14/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 08/14/2024 11:30:00 AM
- Form 424B1 - Prospectus [Rule 424(b)(1)] • Edgar (US Regulatory) • 08/08/2024 09:19:13 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/08/2024 04:15:19 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/30/2024 10:17:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 12:00:30 PM
- Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model • GlobeNewswire Inc. • 06/27/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:15:35 PM
- Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance • GlobeNewswire Inc. • 06/12/2024 11:30:00 AM
- Consolidated Water Comments on ISS and Glass Lewis Reports and Urges Stockholders to Vote “FOR” Re-Election of Its Highly Qualified Directors • GlobeNewswire Inc. • 05/20/2024 05:04:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:43:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 06:54:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:16:08 PM
- Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 05/14/2024 08:05:00 PM
- Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM